# Cancer Biomarker Normal Ranges - Medical Reference

## Blood Cell Markers

### Hemoglobin (Hb)
- **Normal Range**: 
  - Male: 13.5-17.5 g/dL
  - Female: 12.0-15.5 g/dL
- **Elevated**: Above normal range
- **Critical**: < 7.0 g/dL or > 20 g/dL
- **Clinical Significance**: Low levels may indicate anemia, high levels may indicate polycythemia

### White Blood Cell Count (WBC)
- **Normal Range**: 4.0-11.0 K/μL (thousands per microliter)
- **Elevated**: 11.1-30.0 K/μL
- **Critical**: > 30.0 K/μL or < 2.0 K/μL
- **Clinical Significance**: Elevated in infections, leukemia; low in bone marrow disorders

### Platelet Count (PLT)
- **Normal Range**: 150-400 K/μL
- **Low**: 50-150 K/μL
- **Critical**: < 50 K/μL or > 1000 K/μL
- **Clinical Significance**: Low in thrombocytopenia, high in myeloproliferative disorders

## Genetic Markers

### JAK2 V617F Mutation (Ct_JAK2_V617F)
- **Normal Range**: 20-30 Ct (Cycle threshold)
- **Elevated**: 15-19.9 Ct
- **Critical**: < 15 Ct (strong positive)
- **Clinical Significance**: Mutation associated with myeloproliferative neoplasms

### TP53 Mutation
- **Normal**: Wild-type (no mutation)
- **Abnormal**: Any mutation detected
- **Clinical Significance**: Tumor suppressor gene, mutations in many cancers

## Tumor Markers

### CA 19-9 (Carbohydrate Antigen 19-9)
- **Normal Range**: < 37 U/mL
- **Elevated**: 37-120 U/mL
- **Critical**: > 120 U/mL
- **Clinical Significance**: Pancreatic, colorectal, gastric cancers

### CEA (Carcinoembryonic Antigen)
- **Normal Range**: < 3.0 ng/mL (non-smokers), < 5.0 ng/mL (smokers)
- **Elevated**: 3.0-10.0 ng/mL
- **Critical**: > 10.0 ng/mL
- **Clinical Significance**: Colorectal, lung, breast cancers

### AFP (Alpha-Fetoprotein)
- **Normal Range**: < 10 ng/mL
- **Elevated**: 10-400 ng/mL
- **Critical**: > 400 ng/mL
- **Clinical Significance**: Liver cancer, germ cell tumors

### PSA (Prostate-Specific Antigen)
- **Normal Range**: < 4.0 ng/mL
- **Elevated**: 4.0-10.0 ng/mL
- **Critical**: > 10.0 ng/mL
- **Clinical Significance**: Prostate cancer screening

### CA 125
- **Normal Range**: < 35 U/mL
- **Elevated**: 35-200 U/mL
- **Critical**: > 200 U/mL
- **Clinical Significance**: Ovarian cancer

## Metabolic Markers

### Lactate Dehydrogenase (LDH)
- **Normal Range**: 140-280 U/L
- **Elevated**: 280-500 U/L
- **Critical**: > 500 U/L
- **Clinical Significance**: Tissue damage, lymphoma, leukemia

### Alkaline Phosphatase (ALP)
- **Normal Range**: 44-147 U/L
- **Elevated**: 147-300 U/L
- **Critical**: > 300 U/L
- **Clinical Significance**: Bone metastases, liver disease

## Implementation Notes

- Status calculation should be gender-specific where applicable
- Age-adjusted ranges may be needed for some markers
- Multiple abnormal markers increase cancer risk assessment
- Trending over time is more significant than single values
